Health In Tech receives Nasdaq bid-price deficiency notice; 180 days to cure

Health In Tech, Inc.

On April 28, 2025, Nasdaq notified Health In Tech that its Class A common stock (HIT) failed to maintain minimum $1.00 bid price for 30 consecutive business days.
Company has until October 27, 2025 to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not cured, the company may seek an additional 180-day extension by meeting other listing standards and providing a plan (e.g., reverse stock split).
No immediate effect on listing or trading; stock continues to trade on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.